531 related articles for article (PubMed ID: 20489451)
1. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
Ang BU; Spivak RM; Nah HD; Kirschner RE
J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
[TBL] [Abstract][Full Text] [Related]
2. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
3. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
4. Apert syndrome mutant FGFR2 and its soluble form reciprocally alter osteogenesis of primary calvarial osteoblasts.
Suzuki H; Suda N; Shiga M; Kobayashi Y; Nakamura M; Iseki S; Moriyama K
J Cell Physiol; 2012 Sep; 227(9):3267-77. PubMed ID: 22105374
[TBL] [Abstract][Full Text] [Related]
5. Dura cells in the etiopathogenesis of Crouzon syndrome: the effects of FGFR2 mutations in the dura cells on the proliferation of osteoblasts through the hippo/YAP mediated transcriptional regulation pathway.
Dong XH; Zhang MZ; Lai CZ; Li CC; Du L; Song GD; Zong XL; Jin XL
Am J Transl Res; 2021; 13(10):11255-11270. PubMed ID: 34786056
[TBL] [Abstract][Full Text] [Related]
6. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
[TBL] [Abstract][Full Text] [Related]
8. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
9. A Pro253Arg mutation in fibroblast growth factor receptor 2 (Fgfr2) causes skeleton malformation mimicking human Apert syndrome by affecting both chondrogenesis and osteogenesis.
Yin L; Du X; Li C; Xu X; Chen Z; Su N; Zhao L; Qi H; Li F; Xue J; Yang J; Jin M; Deng C; Chen L
Bone; 2008 Apr; 42(4):631-43. PubMed ID: 18242159
[TBL] [Abstract][Full Text] [Related]
10. Co-culture of osteoblasts with immature dural cells causes an increased rate and degree of osteoblast differentiation.
Spector JA; Greenwald JA; Warren SM; Bouletreau PJ; Crisera FE; Mehrara BJ; Longaker MT
Plast Reconstr Surg; 2002 Feb; 109(2):631-42; discussion 643-4. PubMed ID: 11818846
[TBL] [Abstract][Full Text] [Related]
11. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
Greenwald JA; Mehrara BJ; Spector JA; Warren SM; Crisera FE; Fagenholz PJ; Bouletreau PJ; Longaker MT
J Bone Miner Res; 2000 Dec; 15(12):2413-30. PubMed ID: 11127206
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of craniosynostosis: recombinant Noggin inhibits coronal suture closure in the rat craniosynostosis model.
Shen K; Krakora SM; Cunningham M; Singh M; Wang X; Hu FZ; Post JC; Ehrlich GD
Orthod Craniofac Res; 2009 Aug; 12(3):254-62. PubMed ID: 19627528
[TBL] [Abstract][Full Text] [Related]
13. Effects of FGFR Signaling on Cell Proliferation and Differentiation of Apert Dental Cells.
Lu C; Huguley S; Cui C; Cabaniss LB; Waite PD; Sarver DM; Mamaeva OA; MacDougall M
Cells Tissues Organs; 2016; 201(1):26-37. PubMed ID: 26613250
[TBL] [Abstract][Full Text] [Related]
14. A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome.
Tanimoto Y; Yokozeki M; Hiura K; Matsumoto K; Nakanishi H; Matsumoto T; Marie PJ; Moriyama K
J Biol Chem; 2004 Oct; 279(44):45926-34. PubMed ID: 15310757
[TBL] [Abstract][Full Text] [Related]
15. Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders.
Fragale A; Tartaglia M; Bernardini S; Di Stasi AM; Di Rocco C; Velardi F; Teti A; Battaglia PA; Migliaccio S
Am J Pathol; 1999 May; 154(5):1465-77. PubMed ID: 10329600
[TBL] [Abstract][Full Text] [Related]
16. Mandibular dysmorphology due to abnormal embryonic osteogenesis in FGFR2-related craniosynostosis mice.
Motch Perrine SM; Wu M; Stephens NB; Kriti D; van Bakel H; Jabs EW; Richtsmeier JT
Dis Model Mech; 2019 May; 12(5):. PubMed ID: 31064775
[TBL] [Abstract][Full Text] [Related]
17. A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
Guenou H; Kaabeche K; Mée SL; Marie PJ
Hum Mol Genet; 2005 Jun; 14(11):1429-39. PubMed ID: 15829502
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Yes-Associated Protein on the Interaction Between the MEK/Extracellular Signal-Regulated Kinase and Hippo Pathways in Osteoblasts Co-Cultured With Fibroblast Growth Factor Receptor 2-Mutated Dura Cells.
Dong X; Zhang M; Li C; Lai C; Song G; Jin X
J Craniofac Surg; 2022 Jun; 33(4):1250-1254. PubMed ID: 36041089
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide stimulates proliferation and differentiation of fetal calvarial osteoblasts and dural cells.
Lin IC; Smartt JM; Nah HD; Ischiropoulos H; Kirschner RE
Plast Reconstr Surg; 2008 May; 121(5):1554-1566. PubMed ID: 18453977
[TBL] [Abstract][Full Text] [Related]
20. Increased EFG- and PDGFalpha-receptor signaling by mutant FGF-receptor 2 contributes to osteoblast dysfunction in Apert craniosynostosis.
Miraoui H; Ringe J; Häupl T; Marie PJ
Hum Mol Genet; 2010 May; 19(9):1678-89. PubMed ID: 20124286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
